002773 康弘藥業
按盤價 
19.380 +0.160 (+0.832%)
19.380 +0.160 (+0.832%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 3,411,293 | 13.75% | 3,957,460 | 3,389,028 | 3,605,347 | 3,295,430 | |
| 減：營業總成本 | 2,311,766 | 11.92% | 2,807,068 | 2,475,902 | 3,165,611 | 3,916,647 | |
| 其中:營業成本 | 345,306 | 5.78% | 438,409 | 388,035 | 354,606 | 329,737 | |
| 財務費用 | (46,377) | 17.65% | (52,353) | (44,944) | (34,328) | (26,982) | |
| 資產減值損失 | (746) | -689.85% | (231) | (4,127) | (216,033) | (507) | |
| 公允價值變動收益 | (1,387) | 535.16% | (833) | -- | -- | -- | |
| 投資收益 | 20,318 | -6.98% | 45,032 | 38,064 | 26,426 | 34,088 | |
| 其中：對聯營企業和合營企業的投資收益 | (200) | -20.95% | (207) | (748) | (620) | (456) | |
| 營業利潤 | 1,148,723 | 15.41% | 1,261,068 | 1,015,368 | 355,177 | (512,288) | |
| 利潤總額 | 1,138,171 | 15.88% | 1,233,917 | 1,030,296 | 393,420 | (519,513) | |
| 減：所得稅費用 | 173,281 | 4.39% | 202,793 | 164,485 | (27,660) | (249,660) | |
| 淨利潤 | 964,890 | 18.22% | 1,031,124 | 865,811 | 421,081 | (269,853) | |
| 減：非控股權益 | (8,822) | -3.63% | (13,642) | (30,859) | (4) | -- | |
| 股東淨利潤 | 973,712 | 17.97% | 1,044,766 | 896,670 | 421,084 | (269,853) | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.060 | 17.78% | 1.140 | 0.980 | 0.460 | -0.310 | |
| 每股派息 (元) * | -- | -- | 0.380 | 0.150 | 0.100 | 0.100 | |
| 每股淨資產 (元) * | 9.171 | 11.20% | 8.488 | 7.506 | 6.623 | 6.246 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | -- | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 19/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
